Bioinformatic Analysis and Identification of Epitopic Regions of Newcastle Disease Virus F Protein

Document Type : Analytic Review

Authors

1 Razi Vaccine and Research Institute

2 Razi Vaccine and Serum Research Institute

3 Department of Medical Biotechnology, Faculty of Medical Sciences, Tarbiat Modares University

Abstract
Newcastle disease virus (NDV) causes one of the most dangerous infections in birds. High economic losses and high mortality are outcomes of this virus, which does not have any immediate cure. The natural reservoir of this virus can remain among bird and non-bird animals like farm animals. In Iran, this virus has reached a steady situation. Also, it should be mentioned that migrating birds can transfer the virus. The F protein of the virus is essential in pathogenicity and determination of pathogenic strain of NDVs, which has the regions that are essential in pathogenicity, immunogenicity, cell fusibility, and tissue necrosis. In this study, with computational analysis of this protein, some features related to this protein such as protein cleavage site, the conserved region in immunogenicity, infected species in Middle Eastern countries, and physicochemical properties of protein were determined. Results showed that the F protein of NDV consists of highly conserved regions that show a high rate of similarity and identity. Despite the majority of strains characterized as pathogenic, there were still non-pathogenic strains circulating in the Middle East. In this comprehensive study, protein regions essential in immunogenicity and epitope formation were identified, which may be used in the development of recombinant vaccines against this virus.

Keywords

Subjects


1. Alexander, D.J., Aldous, E.W., and Fuller. C.M. )2012(The long view: a selective review of 40 years of Newcastle disease research. Avian Pathol. 41(4), 329-35.
2. Altschul, S.F., Gish, W. Miller, W. Myers, E.W. and Lipman, D.J. )1990(Basic local alignment search tool. J. Mol. Biol. 215(3), 403-10.
3. Ansori, A.N., and Kharisma, V.D. )2020(Characterization of Newcastle disease virus in Southeast Asia and East Asia: Fusion protein gene. EKSAKTA: J. Sci. Data Anal. 20(1),14-20.
4. Ayala, A.J., Dimitrov, K.M., Becker, C.R., Goraichuk, I.V., Arns, C.W., Bolotin, V.I., Ferreira, H.L., Gerilovych, A.P., Goujgoulova, G.V., Martini, M.C., and Muzyka, D.V. (2016) Presence of vaccine-derived Newcastle disease viruses in wild birds. PloS one 11(9), e0162484.
5. Brown, V.R., and Bevins, S.N. (2017) A review of virulent Newcastle disease viruses in the United States and the role of wild birds in viral persistence and spread. Vet. Res. 48(1), 1-5.
6. de Leeuw, O., and Peeters, B. (1999) Complete nucleotide sequence of Newcastle disease virus: evidence for the existence of a new genus within the subfamily Paramyxovirinae. J. Gen. Virol. 80(1), 131-6.
7. Dimitrov, K.M., Ferreira, H.L., Pantin-Jackwood, M.J., Taylor, T.L., Goraichuk, I.V., Crossley, B.M., Killian, M.L., Bergeson, N.H., Torchetti, M.K., Afonso, C.L., and Suarez, D.L. (2019) Pathogenicity and transmission of virulent Newcastle disease virus from the 2018–2019 California outbreak and related viruses in young and adult chickens. Virology 531, 203- 18.
8. Dimitrov, K.M., Afonso, C.L., Yu, Q., and Miller, P.J. 2017. Newcastle disease vaccines—A solved problem or a continuous challenge? Vet. Microbiol. 206: 126-36.
9. Dortmans, J.C., Koch, G., Rottier, P.J., and Peeters, B.P. (2011) Virulence of Newcastle disease virus: what is known so far? Vet. Res. 42(1), 122.
10. Doytchinova, I.A., and Flower, D.R. (2007) VaxiJen: a server for prediction of protective antigens, tumor antigens and subunit vaccines. BMC Bioinform. 8(1), 4.
11. Elamin, M.G., Khalafalla, A.I., and Ahmed, S.M. (1993) Observations on the use of Komarov strain of Newcastle disease vaccine in the Sudan. Trop. Anim. Health Prod. 25(3), 151-4.
12. Errington, W., and Emmerson, P.T. (1997) Assembly of recombinant Newcastle disease virus nucleocapsid protein into nucleocapsid-like structures is inhibited by the phosphoprotein. J. Gen. Virol. 78(9), 2335-9.
13. Hall, T.A., (1999) BioEdit: a user-friendly biological sequence alignment editor and analysis program f or Windows 95/98/NT. In: Nucleic Acids Symposium Series 41. PP 95-98.
14. Heiden, S., Grund, C., Röder, A., Granzow, H., Kühnel, D., and Mettenleiter, T.C. 2014. Römer-Oberdörfer A. Different regions of the newcastle disease virus fusion protein modulate pathogenicity. PLoS One 9(12), e113344.
15. Gasteiger, E., Hoogland, C., Gattiker, A., Wilkins, M.R., Appel, RD., and Bairoch, A. (2005) Protein identification and analysis tools on the ExPASy server. PP 571-607. In: J.M. Walker (ed) The Proteomics Protocols Handbook. Springer Protocols Handbooks. Humana Press.
16. Gasteiger, E., Gattiker, A., Hoogland, C., Ivanyi, I., Appel, R.D., and Bairoch, A. (2003) ExPASy: the proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res. 31(13), 3784-3788.
17. Glickman, R.L., Syddall, R.J., Iorio, R.M., Sheehan, J.P., and Bratt,M.A.. (1988) Quantitative basic residue requirements in the cleavage-activation site of the fusion glycoprotein as a determinant of virulence for Newcastle disease virus. J. Virol 62(1), 354-6.
18. Jahanshiri, F., Eshaghi, M., and Yusoff, K. (2005) Identification of phosphoprotein: phosphoprotein and phosphoprotein: nucleocapsid protein interaction domains of the Newcastle disease virus. Arch. Virol. 150(3), 611-8.
19. Kim, S.H., Wanasen, N., Paldurai, A., Xiao, S., Collins, P.L., and Samal, S.K. (2013.) Newcastle disease virus fusion protein is the major contributor to protective immunity of genotype-matched vaccine. PloS one 8(8), e74022.
20. Kim, L.M., Suarez, D.L., and Afonso, C.L. (2008) Detection of a broad range of class I and II Newcastle disease viruses using a multiplex real-time reverse transcription polymerase chain reaction assay. J. Vet. Diagn. Invest. 20(4), 414-25.
21. Larsen, J.E., Lund, O., and Nielsen, M. 2006. Improved method for predicting linear B-cell epitopes. Immunome Res. 2(1): 1-7.
22. Mohamed, M.H., Kumar, S., Paldurai, A., and Samal, S.K. (2011) Sequence analysis of fusion protein gene of Newcastle disease virus isolated from outbreaks in Egypt during 2006. Virol. J. 8(1), 1-4.
23. Morrison, T.G. (2003) Structure and function of a paramyxovirus fusion protein. Arch. Biochem. Biophys. 1614(1), 73-84.
24. Pedersen, J.C., Senne, D.A., Woolcock, P.R., Kinde, H., King, D.J., Wise, M.G., Panigrahy, B., and Seal, B.S. (2004) Phylogenetic relationships among virulent Newcastle disease virus isolates from the 2002-2003 outbreak in California and other recent outbreaks in North America. J. Clin. Microbiol 42(5), 2329-34.
25. Snoeck, C.J., Adeyanju, A.T., Owoade, A.A., Couacy-Hymann, E., Alkali, B.R., Ottosson, U., Muller, C.P. (2013) Genetic diversity of Newcastle disease virus in wild birds and pigeons in West Africa. Appl. Environ. Microbiol. 79(24),7867-74.
26. Swanson, K., Wen, X., Leser, G.P., Paterson, R.G., Lamb, R.A., and Jardetzky, T.S. (2010) Structure of the Newcastle disease virus F protein in the post-fusion conformation. Virology 402(2), 372-9.
27. Toyoda, T., Sakaguchi, T., Imai, K., Inocencio, N.M., Gotoh, B., Hamaguchi, M., and Nagai, Y. (1987) Structural comparison of the cleavage-activation site of the fusion glycoprotein between virulent and avirulent strains of Newcastle disease virus. Virology 158(1), 242-7.
28. Wang, J.Y., Liu, W.H., Ren, J.J., Tang, P., Wu, N., Wu, H.Y., Ching, C.D., and Liu, H.J. (2015) Characterization of emerging Newcastle disease virus isolates in China. Virol. J. 12(1), 1-21.
29. Winterfield, R.W., Dhillon, A.S., and Alby, L.J. (1980) Vaccination of chickens against Newcastle disease with live and inactivated Newcastle disease virus. Poult. Sci. 59(2), 240-6.
30. Yuan, X., Wang, Y., Yang, J., Xu, H., Zhang, Y., Qin, Z., Ai, H., and Wang, J. (2012) Genetic and biological characterizations of a Newcastle disease virus from swine in china. Virol. J. 9(1), 129.
31. Mozafari, A., Amani, J., Shahsavandi, S., Hatef Salmanian, A. (2022) A Novel Multi-Epitope Edible Vaccine Candidate for Newcastle Disease Virus: In Silico Approach. Iran J Biotechnol. 20(2):e3119.
32. Hu, S., Wang, T., Liu, Y., Meng, C., Wang, X., Wu, Y., Liu, X. (2010) Identification of a variable epitope on the Newcastle disease virus hemagglutinin–neuraminidase protein, Vet. Microbiol. 140(1), 92-97.